Purchase Order VA24117P2243

This firm-fixed-price purchase order was awarded by the Defense Health Agency to Lifenet Health, a non-profit organization and manufacturer of regenerative medicine products based in Virginia Beach, Virginia. The $24,014 contract is for the delivery of BL-1500-003 VIVIGEN 10CC CELL BNE MTRX, which are cellular bone matrix grafts. Lifenet Health is a global leader in the recovery, preservation, and distribution of human organs and tissues for transplantation, as well as the development of...

This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Bioventus LLC, a self-certified small disadvantaged business manufacturer of medical devices and rehabilitation systems. The contract, valued at $40,940.00, is for the safety and gait maintenance, as well as software updates, of Bioness Vector devices used in the VA healthcare system. The contract has an ultimate completion date of July 30, 2023. Bioventus LLC has been a long-standing...

This federal contract award to Regenesis Biomedical Inc. is for the supply of the company's Provant Therapy System medical device and related rental/leasing services to the U.S. Department of Veterans Affairs (VA). The $4,882.79 firm-fixed-price purchase order was awarded on February 16, 2011, with a completion date of March 16, 2011. The contract was awarded against Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract for medical equipment and...

This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the provision of Regenesis Biomedical's proprietary Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of January 27, 2011. Regenesis Biomedical is the prime...

This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $7,142.85 firm fixed-price purchase order contract is for the provision of Regenesis Biomedical's Provant Therapy System, a patented noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract is not associated with any set-aside designations. Regenesis Biomedical,...

This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of January 20, 2011. Regenesis Biomedical has provided the Provant Therapy System and related rental...

This firm-fixed-price purchase order was awarded by the Veterans Integrated Service Network 9 (VISN 9), a healthcare network within the U.S. Department of Veterans Affairs (VA), to Bioventus LLC, a self-certified small disadvantaged business. The $12,780.72 contract is for the delivery of an electrical hand stimulus device. Bioventus LLC is a manufacturer of medical devices, rehabilitation systems, and surgical implants that specializes in providing equipment and services to VA healthcare...

This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc. for the company's Provant Therapy System, a non-invasive regenerative medicine product. The $7,055.10 firm fixed-price purchase order is for the supply and rental/leasing of the Provant Therapy System devices to VA medical facilities. This contract is under Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract for medical equipment and supplies....

This is a federal contract award by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $7,055.10 firm-fixed-price purchase order is for the Provant Therapy System, a patented regenerative medicine product indicated for post-operative pain and edema treatment. The contract has an ultimate completion date of March 10, 2011. Regenesis Biomedical is the prime contractor and there is no indication of any subcontractors. The...

This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical device manufacturer. The contract, valued at $3,645.14, is for the provision of Regenesis Biomedical's Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract does not have a set-aside designation. Regenesis Biomedical Inc. is the prime contractor and...